F0U.F NAVCO Pharmaceuticals Inc.

Healthcare Drug Manufacturers - Specialty & Generic Frankfurt Exchange
0.0010 EUR
Close of Nov 12, 2026
0.0010 0.0070
Market cap
EUR 57.1K
P/E
-
P/B
-
ROE
-2,698.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2022.

Is F0U.F undervalued?

Graham number

The Graham number of NAVCO Pharmaceuticals Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NAVCO Pharmaceuticals Inc. fundamental analysis

No fundamental analysis for NAVCO Pharmaceuticals Inc. yet.

NAVCO Pharmaceuticals Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NAVCO Pharmaceuticals Inc.

NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives indu…

Full company profile